Investor List:

Top Pharmaceuticals Series A Investors in New York City (132)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of David Bonita, General Partner at OrbiMed
David Bonita
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Jonathan Rosenbaum, General Partner at Waldo
Jonathan Rosenbaum
Waldo·General Partner
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in AI (Series B), Investors in Pharmaceuticals (Seed), Investors in Education (Series B), Investors in Education (Series A), Investors in Enterprise (Series B), Investors in Education (Seed), Investors in Pharmaceuticals (Series B), Investors in AI (Seed), Investors in FinTech (Series B), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in AI (Seed), Investors in SaaS (Series B), Investors in Enterprise (Series A), Investors in Education (Seed), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in SaaS (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Series A), Investors in Education (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in FinTech (Series B), Investors in Enterprise (Series B), Investors in Education (Series B), Investors in Pharmaceuticals (Series B), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in Enterprise (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed)
Photo of Jared Newman, Partner at Daybreak Partners
Jared Newman
Sweet spot: $10.0M
Range: $250K - $20.0M
Investors in New York City
Photo of Michael Aberman, General Partner at Regeneron Ventures
Michael Aberman
Regeneron Ventures·General Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
Photo of Sara Nayeem, Partner at Avoro Ventures
Sara Nayeem
Sweet spot: $1M
Range: $100K - $10.0M
Investors in New York City, Investors in Washington (DC)
Photo of Justine Potemkin, Investor at Global Health Investment Corporation
Justine Potemkin
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in New York City
Photo of Sven Borho, Managing Partner at OrbiMed
Sven Borho
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
Photo of W. Carter Neild, Managing Partner at OrbiMed
W. Carter Neild
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)